BowTiedBiotech

BowTiedBiotech

Home
Chat
News
Market Insights
Stocks
Strategy
Books
X-Articles
The BowtiedBiotech Podcast
Archive
Leaderboard
About
Mastering Biotech Markets with the SPEED Framework | Ep. 909
Historical Cycles, Pricing Psychology, and the Path Ahead to 2030
1 hr ago
Most Popular
View all
Week 47 -  Shaky Public Markets but Innovative Science Continues to Attract Capital 
Nov 26, 2021 • BowTiedBiotech
The Next Generation of Multi-Functional I&I Therapeutics | Ep. 873
Dec 7, 2025
Week 48: Always Follow the Money $$
Dec 2, 2021 • BowTiedBiotech
Weekly Biotech News Fix | Ep. 908
The week of 1.12.25
Jan 17 • BowTiedBiotech
17:34
Your Weekly Biotech News Fix | Ep. 907
The week of 1.12.25
Jan 16
Reset Week in San Francisco | Ep. 906
Key Take Aways from This Years Conference
Jan 15
2025 Research Signals | Ep. 905
How the biology showing up now reshapes post-2030 biotech
Jan 14
17:36
BIOTECH MARKET RESEARCH $BEAM | Ep. 904
Beam Therapeutics
Jan 12
The Next Generation of Multi-Functional I&I Therapeutics | Ep. 903
How to Pick Winners From a Crowded Cytokine War
Jan 11
Weekly Biotech News Fix | Ep. 902
The week of 1.5.25
Jan 10 • BowTiedBiotech
16:22
BowTiedBiotech
BowTiedBiotech
Daily Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends
Recommendations
View all 10
The Options Oracle
The Options Oracle
Edward Corona
Big Pharma Sharma
Big Pharma Sharma
Big Pharma Sharma
Asymmetric Learning - Pharmaceutical Innovation
Asymmetric Learning - Pharmaceutical Innovation
Mike Rea, SAI/ IDEA Pharma
Dr. EvoluSean's Toolbox
Dr. EvoluSean's Toolbox
Sean Jackewicz
BowTied Bull
BowTied Bull
BowTied Bull

BowTiedBiotech

AboutArchiveRecommendationsSitemap
© 2026 BowTiedBiotech · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture